GWS
IDXX icon

Greykasell Wealth Strategies’s Idexx Laboratories IDXX Stock Holding History

Greykasell Wealth Strategies’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$42.7K Buy
76
+21
+38% +$13.5K 0.02% 257
2025
Q4 		$37.2K Hold
55
– – 0.01% 263
2025
Q3 		$35.1K Buy
+55
New +$33.4K 0.01% 225

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Greykasell Wealth Strategies's IDXX Position: Q1 2026 in Review

Greykasell Wealth Strategies increased its Idexx Laboratories (IDXX) stake by 38% in Q1 2026, buying an estimated $13.5K and bringing the position to 76 shares worth $42.7K. The position accounts for 0.02% of the portfolio, ranked #257.

Greykasell Wealth Strategies first reported a position in IDXX in Q3 2025 and has held it in 3 quarters since. 1,314 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Greykasell Wealth Strategies held 76 shares of Idexx Laboratories worth $42.7K as of Q1 2026.
  • Greykasell Wealth Strategies bought 21 Idexx Laboratories shares in Q1 2026, an estimated $13.5K.
  • Idexx Laboratories made up 0.02% of Greykasell Wealth Strategies's portfolio in Q1 2026, its #257 holding.
  • Greykasell Wealth Strategies first reported a position in Idexx Laboratories in Q3 2025 and has held it in 3 quarters since.
  • 1,314 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Greykasell Wealth Strategies's 13F filing for Q1 2026, filed 7 May 2026.